Login
From:
PharmaVoice
(Uncensored)
subscribe
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run | PharmaVoice
https://www.pharmavoice.com/news/sanofi-dupixent-regeneron-blockbuster-sales-earnings-q2/722687/
links
backlinks
Dupixent hasn’t generated as much buzz as top-sellers like Keytruda or Ozempic, but the drug is boosting Sanofi’s earnings into the future.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
